European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Aglaris Ltd., London

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Aglaris Ltd.

Register

Chp
Companies House 09111674

Address

167-169 Great Portland Street Great Portland Street, 5th Floor, London W1W 5PF, United Kingdom
F30 Gunnels Wood Road Stevenage Hertfordshire, United Kingdom

Additional info

72.11
Research and experimental development on biotechnology

Financials

Earnings Revenue Employees

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Marketing & Tech

Network

Loading network

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

Publications

27 Apr 2024
Memorandum and Articles of Association
13 Apr 2024
Resolution of allotment of securities · Resolution of removal of pre-emption rights …
28 Mar 2024
Director: 3-Gutinver SL
22 Dec 2023
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022
6 Dec 2023
Patent: Cell Separation Chamber and Cell Separation System and Method
29 Nov 2023
Patent: Disposable Cartridge Cooperating with a Platform for a System and Installation for Monitoring and Controlling Fluids
16 Oct 2023 also 14/10/2022, 12/07/2022, 22/07/2020, 03/07/2019, 16/07/2018
Confirmation statement made with updates
4 Aug 2023
Address
2 Feb 2023
No longer Director: Steven John Docksey
12 Oct 2022
Change of details for Crb Bio Ii, Fcr as a person with significant control
24 Jun 2022
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
29 Nov 2021 also 18/10/2021, 05/06/2018
Statement of capital following an allotment of shares
2 Aug 2021
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
23 Jul 2021 via Aglaris Cell SL
Director: Aglaris Cell SL
1 Jul 2021
Confirmation statement made with updates · Change of details for Crb Bio Ii, Fcr as a person with significant control
16 Jun 2021 also 06/05/2020, 25/09/2018
Resolution of removal of pre-emption rights · Resolution of allotment of securities
25 Feb 2021
Director's details changed for Bio Cell Global Investments S.L
17 Dec 2020 in Hor
EU funding: Artificial Intelligence-driven, Decentralized Production for Advanced Therapies in the Hospital
30 Sept 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
17 Jul 2020
Director's details changed for Bio Cell Global Investments S.L · Director's details changed for Angel José Santos …
6 Jul 2020
Notification of Crb Bio Ii, Fcr as a person with significant control · Withdrawal of a person with significant control …
2 Jul 2020
Registration of charge 091116740001, created
15 Jun 2020
Director: Joaquin Velasco
1 Jun 2020
Termination of appointment of Pablo Cabello Albendea as a director
7 May 2020
Resolution of removal of pre-emption rights · Re-co business 09/04/2020 · Resolution of allotment of securities …
16 Apr 2020
Director's details changed for Mr Steven John Docksey
Year 2019 in Epobase
4 European patent filings: Cell Culture System and Method …
17 Oct 2019
Second filing of a statement of capital following an allotment of shares · Statement of capital following an allotment …
4 Oct 2019 also 06/10/2018, 09/10/2017
Accounts for a small company made up to 2018-12-31
8 Jul 2019
Address
1 Apr 2019 in Fts
EU funding (€1,435,700): 849027 - Facer - the First Cell Culture Platform That Enables Affordable Cell Therapies AT a Large Scale
1 Apr 2019 in Hor
EU funding (€1,435,700): The First Cell Culture Platform that Enables Affordable Cell Therapies at a Large Scale
Year 2018 in Epobase
4 European patent filings: Cell Culture System and Method …
2 Oct 2018
Notification of a person with significant control statement
17 Jul 2018
Director: Steven John Docksey · No longer Director: Francisco Canal Vega
13 Jul 2018
Cessation of David Horna Tomás as a person with significant control · Cessation of Miquel Costa Ferrando as a person …
1 Jul 2018 in Ukri
UK funding (£338,053): Improving T-Cell manufacture through automation - scaling out, reducing costs and increasing quality to meet the emerging demand for patient-tailored cancer therapies.
19 Jul 2017
Loan agreement 10/07/2017 · Resolution of adoption of Articles of Association (ADOPT ARTICLES)
4 Jul 2017
Confirmation statement made with no updates · Director's details changed for Pablo Cabello Albendea
10 Oct 2016
Amended total exemption small company accounts made up to 2015-12-31
6 Oct 2016
Address
27 Jul 2016
Confirmation statement made with updates · Director's details changed for Mr Miquel Costa Ferrando …
1 Jun 2016 in Fts
EU funding (€50,000): 729499 - Aglaris - Aglaris: the First Fully-Automated Bioreactor for Large Scale Human Stem Cell Production through an Iterative Process.
1 Jun 2016 in Hor
EU funding (€50,000): AGLARIS: The First Fully-automated Bioreactor for Large Scale Human Stem Cell Production through an Iterative Process.
5 May 2016
Director: Francisco Canal Vega, J. Castillo Gonzalez
2 Apr 2016
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015
29 Mar 2016
Previous accounting period extended from 2015-07-31 to 2015-12-31
8 Feb 2016
Director: Angel Santos Igles
18 Jan 2016
Statement of capital following an allotment of shares · Resolution of adoption of Articles of Association (ADOPT …
6 Nov 2015 via Aglaris Cell SL
Partner: Aglaris Cell SL
15 Oct 2015
No longer Secretary: Flexible Directors Ltd
7 Oct 2015
Appointment of Manuel Fuertes Dominguez as a director
29 Jul 2015
Capital: £1.00
2 Jul 2014
Reg­is­tra­tion: 02/07/2014 · Director: M. Costa Ferrando, David Horna Tomás · Secretary: Flexible Directors Ltd. · Capital: £1.00

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Aglaris Ltd., London" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close